Bone Biopsy Market Research Report - Global Forecast till 2027

Bone Biopsy Market Research Report: Information by Type (Needle Biopsy and Open Biopsy), Guidance (MRI Guided and CT Guided), and End Users (Hospitals and Clinics, Surgical Centers, and Others), and Region (Americas, Europe, Asia-Pacific, Middle East & Africa)— Forecast till 2027

ID: MRFR/MED/3898-HCR | | Region: Global | 110 pages         

Bone Biopsy Market Speak to Analyst Request a Free Sample

Bone Biopsy Market Scenario

The bone biopsy market is expected to register ~4.5% CAGR during the forecast period of 2019 to 2025 and is expected to reach USD 718 million by 2025. Bone biopsy is a procedure, in which a sample of cells or tissues are collected from the bone for examination. The procedure is generally performed to confirm the presence of bone cancer, investigation of a lesion, and identify the cause of inflammation or infection. Furthermore, factors such as stringent regulatory policies, product recall, and others are hampering the growth of the market.  

Segmentation

The bone biopsy market is segmented on type, guidance, end users, and region. The global market for bone biopsy, by type, is segmented into needle biopsy and open biopsy. Based on guidance, the global market is divided into guided and non-guided, where the guided segment is further sub-segmented into MRI-guided and CT-guided. The guided segment is expected to hold the highest market share due to the clinical advantages over its non-guided counterparts. The end user segment consists of hospitals & clinics, specialty centers, and others. The hospitals & clinics segment is expected to dominate the market due to the increasing number of hospitals. In the current scope of the study, the segments mentioned above are covered under four regions, namely, the Americas, Europe, Asia-Pacific, and the Middle East & Africa. The bone biopsy market in the Americas has further been segmented into North America and South America, with the North American market divided into the US and Canada. The European bone biopsy market has been segmented into Western Europe and Eastern Europe. Western Europe has been classified as Germany, France, the UK, Italy, Spain, and the rest of Western Europe.  The bone biopsy market in Asia-Pacific has been segmented into Japan, China, India, South Korea, Australia, and the rest of Asia-Pacific. The bone biopsy market in the Middle East & Africa has been segmented into the Middle East and Africa.  

Key Players

Some of the key players operating in the bone biopsy market are BD (US), B. Braun Melsungen AG (Germany), Cook (US), GENERAL ELECTRIC COMPANY (US), ARGON MEDICAL (US), MERMAID MEDICAL A/S (Denmark), Ranfac Corp. (US), Kimal (UK), and Remington Medical (US).  


Regional Market Summary Bone Biopsy Market Share (%), by Region, 2018 Sources: MRFR Analysis   The Americas dominated the bone biopsy market owing to the high prevalence of bone cancer and presence of major manufacturers in the region. In 2018, Europe accounted for the second-largest market share. However, Asia-Pacific is expected to register the fastest CAGR due to increasing awareness regarding bone cancer and growing healthcare infrastructure. On the other hand, the Middle East & Africa is expected to hold the least share in the bone biopsy market due to limited access to health facilities and lack of awareness regarding health management.

Bone Biopsy Market, by Type


  • Needle Biopsy

  • Open Biopsy


Bone Biopsy Market, by Guidance



  • GuidedMRI-Guided

  • CT-Guided

  • Non-Guided


Bone Biopsy Market, by End User



  • Hospitals and Clinics

  • Surgical Centers

  • Others


Bone Biopsy Market, by Region



  • Americas


    • North America

    • US

    • Canada




  • Europe


    • Western Europe

    • Germany

    • France

    • Italy

    • Spain

    • UK

    • Rest of Western Europe

    • Eastern Europe




  • Asia-Pacific


    • Japan

    • China

    • India

    • Australia

    • South Korea

    • Rest of Asia-Pacific




  • Middle East & Africa


    • Middle East

    • Africa



Intended Audience



  • Medical device manufacturers

  • Government research institutes

  • Academic institutes and universities

  • Venture capitalists



Report Scope:
Report Attribute/Metric Details
  Market Size   USD 718 million (2025)
  CAGR   4.5% (2020-2027)
  Base Year   2019
  Forecast Period   2020-2027
  Historical Data   2018
  Forecast Units   Value (USD Million)
  Report Coverage   Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
  Segments Covered   type, guidance, end users
  Geographies Covered   North America, Europe, Asia-Pacific, and Rest of the World (RoW)
  Key Vendors   BD (US), B. Braun Melsungen AG (Germany), Cook (US), GENERAL ELECTRIC COMPANY (US), ARGON MEDICAL (US), MERMAID MEDICAL A/S (Denmark), Ranfac Corp. (US), Kimal (UK), and Remington Medical (US).
  Key Market Opportunities

  • stringent regulatory policies
  • product recall
  •   Key Market Drivers   high prevalence of bone cancer


    Speak to Analyst Ask for Customization

    Frequently Asked Questions (FAQ) :

    Global bone biopsy market is expected to expand at 4.5% CAGR from 2019 to 2025.

    Global bone biopsy market can touch USD 718 million by 2025.

    Rising prevalence of bone cancer is the primary driver of the global bone biopsy market.

    Recall of products and strict regulatory policies are factors expected to impede the global gastric bypass market growth.

    The Americas is expected to dominate in the global bone biopsy market till 2023 due to high prevalence of bone cancer.

    GENERAL ELECTRIC COMPANY, Cook, Kimal, Remington Medical, ARGON MEDICAL, BD, B. Braun Melsungen AG, Ranfac Corp., and MERMAID MEDICAL A/S are prominent players of the global bone biopsy market.